Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs

In this podcast, we are joined by a special guest, Dr. Brian Short, who shares his expert insights into the critical factors involved in developing ophthalmic drugs. From overcoming the unique challenges of drug delivery to the eye’s complex structure to navigating regulatory requirements and optimizing formulation strategies, Dr. Short provides a comprehensive look at what it takes to bring successful ophthalmic therapies to market.

During our discussion, we explore key considerations such as bioavailability, patient safety, preclinical and clinical study design, and the latest advancements in ophthalmic drug development. Whether you're a researcher, clinician, or industry professional, this episode offers valuable knowledge and practical guidance on accelerating innovation in the ophthalmic space.